Standout Papers

Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chro... 1998 2026 2007 2016 1.0k
  1. Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C (1998)
    Gary L. Davis, Rafael Esteban et al. New England Journal of Medicine

Immediate Impact

11 by Nobel laureates 12 from Science/Nature 95 standout
Sub-graph 1 of 14

Citing Papers

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Global cancer statistics, 2012
2015 Standout
22 intermediate papers

Works of John C. Hoefs being referenced

Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma
2009
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial
2006
and 6 more

Author Peers

Author Last Decade Papers Cites
John C. Hoefs 3719 3353 825 73 5.0k
G Korb 3807 3823 740 79 5.7k
Dar‐In Tai 3867 4048 600 94 5.4k
J. De Groote 4397 4389 925 67 6.3k
Chuan–Mo Lee 4214 4193 764 119 5.8k
Luigi Elio Adinolfi 3666 4378 543 136 6.1k
Patrice Couzigou 5314 5762 792 133 7.3k
Thomas J. Layden 3665 3609 803 119 6.3k
Pierluigi Toniutto 2626 2507 914 176 4.1k
Vincent Mallet 3628 3623 707 124 5.7k
Akihiro Matsumoto 3048 3262 565 130 4.3k

All Works

Loading papers...

Rankless by CCL
2026